GlassScriptPhysician profile
Lewis John Eyrich
NPI 1043448053
$1,448.82
in general payments reported to CMS, 2019-2025
17 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.95 · 2021: $258 · 2022: $475 · 2023: $222 · 2024: $195 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Notal Vision, INC. | $347.71 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $178.43 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $173.60 | 2022-2025 | Infuse, Alden Scleral Zenlens, Miebo |
| Alcon Vision LLC | $150.98 | 2022-2025 | Total30, Rocklatan, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $130.00 | 2021-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $84.68 | 2021-2023 | Cequa |
| Rxsight INC | $72.95 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abbvie INC. | $57.95 | 2022-2024 | |
| Allergan, INC. | $42.10 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.92 | 2021 | |
| Thea Pharma INC. | $40.72 | 2023-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $25.39 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.60 | 2022 | |
| Kala Pharmaceuticals, INC. | $22.33 | 2021 | |
| Aerie Pharmaceuticals, INC. | $20.95 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $20.90 | 2025 | Idosetr |
| Apellis Pharmaceuticals, INC. | $14.61 | 2025 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Eyrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.